Walgreens Considers Selling UK Pharmacy Chain Boots
Walgreens Boots Alliance is reportedly exploring options to offload its UK drugstore chain Boots, including a potential initial public offering (IPO) in London. The company is holding early talks about separating Boots, which could be valued at around £7 billion ($8.8 billion) in a deal. Walgreens had previously abandoned a sale process for Boots in 2022 due to valuation concerns. The potential divestment of Boots would provide a boost to the London stock market, which has seen a decline in IPO fundraising this year. Any process is expected to start next year at the earliest.